Arunjyoti Bio Ventures Ltd (PASURA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Arunjyoti Bio Ventures Ltd on NSE and BSE, with an AI summary of each filing.
Change in Registered Office of the Company.
Others (Uncategorized) · 07 Oct 2026, 1:53 am
Pasura Industries Approves Relocation of Registered Office Effective November 2026 Pasura Industries Limited announced that its Board of Directors, via a circular resolution passed on 6th Oct'26, approved shifting the company's registered office within Hyderabad, Telangana. Effective 1st Nov'26, the registered office will move from Jain Sadhguru Capital Park, Madhapur, to Dwaraka Central, Plot No. 57, Survey No. 74 & 75, Jaihind Enclave, Madhapur, Hyderabad – 500081.
Change of Name of the Company from "Arunjyoti Bio Ventures Limited" to "Pasura Industries Limited"
Others (Uncategorized) · 03 Sept 2026, 11:10 pm
Arunjyoti Bio Ventures Announces Official Name Change to Pasura Industries Limited Arunjyoti Bio Ventures Ltd (BSE: 530881) announced its official name change to Pasura Industries Limited, effective 2nd Sep'26, following the issuance of a new Certificate of Incorporation by the Ministry of Corporate Affairs. The company formally notified the BSE on 3rd Sep'26. The corporate identity number (L01400TG1986PLC062463) remains unchanged. This administrative update does not impact shareholder rights or liabilities, though regulatory guidelines mandate displaying both the former and new names across all official company representations for the next two years.
Scrutinizer Report for 40th Annual General Meeting
Annual General Meeting · 13 Aug 2026, 12:26 am
Outcome & Proceedings of 40th Annual General Meeting
Annual General Meeting · 13 Aug 2026, 12:22 am
Annual Report for FY 2025-26 of the Company.
Others (Uncategorized) · 20 Jul 2026, 10:45 pm
Notice of AGM for the FY 2025-26 scheduled to be held on 12.08.2026
Annual General Meeting · 20 Jul 2026, 10:32 pm
Changes in Management
Change in Management · 10 Jul 2026, 12:07 am
Arunjyoti Bio Ventures Q1'27 Results, Name Change, and Key Board Approvals Arunjyoti Bio Ventures reported a Q1'27 Net Profit of ₹61.24 lakh, a significant turnaround from a ₹540.09 lakh loss in Q4'26 but a 70% YoY decline. Revenue was ₹820.00 lakh, up 13.3% QoQ but down 5.9% YoY. The Board approved changing the company name to "Pasura Industries Limited". It also waived the recovery of ₹25.19 lakhs in excess managerial remuneration for FY26 and approved remuneration revisions for key directors. A new secretarial auditor, Vivek Surana & Associates, was appointed for a five-year term.
Un-Audited Financial Results along with Limited Review Report for the Quarter Ended 30.06.2026.
Financial Result · 09 Jul 2026, 11:54 pm
Arunjyoti Bio Ventures Ltd Q1 Results, Name Change, and Managerial Remuneration Approvals Arunjyoti Bio Ventures reported a Q1 FY27 net profit of ₹61.24 lakh, a 70% YoY decline from ₹204.54 lakh, on revenue of ₹820.00 lakh. The board approved a name change to Pasura Industries Limited and waived the recovery of excess managerial remuneration of ₹25.19 lakh for FY26. It also approved significant remuneration revisions for three whole-time directors. The 40th AGM is scheduled for 12th Aug'26. Additionally, the company appointed M/s. Vivek Surana & Associates as secretarial auditors effective 09th Jul'26.
Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2026 ,inter alia, to consider and approve 1. Un-audited Financial ....
Intimation · 09 Jul 2026, 5:30 am
Arunjyoti Bio Ventures Board Meeting Set for Q1 Results Arunjyoti Bio Ventures (Scrip: 530881) has scheduled a Board of Directors meeting on 9th Jul'26. The primary agenda is to consider and approve the un-audited financial results for the first quarter ending 30th Jun'26. The board will also review the Limited Review Report for the same period and may discuss any other business items with the Chair's permission.
Audited Financial Statements for the Quarter and Year ended 31.03.2026
Financial Result · 13 May 2026, 11:44 pm
Arunjyoti Bio Ventures Posts Q4FY26 Loss; Reports Full-Year Loss with Debt Write-Off Arunjyoti Bio Ventures reported a net loss of ₹540.09 lakhs for Q4 ended 31 Mar'26, against a loss of ₹102.55 lakhs YoY. Revenue from operations grew to ₹723.73 lakhs from ₹528.10 lakhs YoY. For FY26, the company posted a net loss of ₹453.61 lakhs compared to a loss of ₹27.62 lakhs in FY25. The board also approved a write-off of outstanding debtors and creditors amounting to ₹273.65 lakhs, which was recorded as an exceptional item in Q4. Basic EPS for Q4 stood at ₹(0.29).
Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
Rescheduled / Cancelled · 12 May 2026, 8:20 pm
Arunjyoti Bio Ventures Board Meeting Postponed by One Day Arunjyoti Bio Ventures Ltd. has postponed its Board Meeting originally scheduled for 12 May'26. The meeting has been rescheduled to 13 May'26. The agenda, which includes the consideration and approval of Audited Financial Results for the quarter and year ended 31 Mar'26, remains unchanged. This update follows earlier intimations dated 01 May'26 and 05 May'26.
Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
Rescheduled / Cancelled · 05 May 2026, 8:27 pm
Arunjyoti Bio Ventures Postpones Board Meeting for Financial Results Arunjyoti Bio Ventures (Scrip: 530881) has postponed its Board Meeting, originally scheduled for 08-May-26. The meeting will now be held on 12-May-26 due to unavoidable reasons. The agenda remains unchanged and includes the consideration and approval of the Audited Financial Results for the quarter and year ended 31-Mar-26.
Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 ,inter alia, to consider and approve Audited Financials results ....
Intimation · 12 May 2026, 5:30 am
Arunjyoti Bio Ventures Board Meeting Scheduled for Q4 FY26 Results Arunjyoti Bio Ventures (Scrip: 530881) announced its Board of Directors will meet on 08 May '26. The key agenda item is the consideration and approval of the audited financial results for the quarter and financial year ended 31 Mar '26.
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Others (Uncategorized) · 30 Apr 2026, 10:20 pm
Arunjyoti Bio Ventures Confirms It Is Not a Large Corporate Arunjyoti Bio Ventures Limited has formally notified the BSE that it does not qualify as a Large Corporate (LC) under the SEBI framework as of 30-Apr-26. This classification exempts the company from the mandatory requirement to raise a portion of its funding through debt securities. The filing covers the annual disclosure for FY26 and indicates no mandatory borrowing obligations or associated shortfalls for the F.Y-2025-26 and F.Y-2026-27 block period.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 30 Apr 2026, 10:14 pm
Arunjyoti Bio Ventures Does Not Qualify as a Large Corporate for FY27 On 30th Apr'26, Arunjyoti Bio Ventures Ltd (BSE: 530881) confirmed it does not qualify as a "Large Corporate" under SEBI's framework for FY27. While its equity shares are listed, it fails to meet the other criteria: outstanding long-term borrowings were only ₹20.57 crore as of 31st Mar'26, far below the ₹1,000 crore threshold, and it does not have the required "AA" or higher credit rating. Therefore, the mandatory borrowing and initial disclosure requirements are not applicable to the company for the financial year 2026-2027.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chennupati Sarath Kumar
Acquisition/ Disposal of Shares · 17 Apr 2026, 3:58 pm
Arunjyoti Bio Ventures: Shareholder Sells 2.91% Stake Chennupati Sarath Kumar sold 54,25,516 shares (a 2.91% stake) of Arunjyoti Bio Ventures via an open market transaction between 13-Apr-26 and 16-Apr-26. This disposal reduced his total holding in the company from 1,41,01,138 shares (7.57% stake) to 86,75,622 shares (4.66% stake). The disclosure, dated 16-Apr-26, confirms the seller does not belong to the promoter group. The company's total voting capital remains unchanged post-transaction.
Clarification in trading of the shares of the Company.
Others (Uncategorized) · 14 Apr 2026, 12:14 am
Arunjyoti Bio Ventures Cautions Investors on Unsolicited Stock Messages Arunjyoti Bio Ventures Ltd. disclosed on 13 Apr'26 that it is aware of unsolicited messages circulating regarding its scrip. The company has advised investors to exercise due care and caution when dealing in its shares. This regulatory filing serves as a formal warning to the market about potential attempts to influence the stock's trading activity.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chennupati Sarath Kumar
Acquisition/ Disposal of Shares · 11 Apr 2026, 10:37 pm
Arunjyoti Bio: Shareholder Sells 3.27% Stake via Open Market Chennupati Sarath Kumar, a non-promoter shareholder, sold 60,97,684 equity shares of Arunjyoti Bio Ventures Ltd (BSE: 530881) through the open market between 23-Mar-26 and 10-Apr-26. This transaction represents 3.27% of the company's total voting capital. Following the sale, Kumar's shareholding decreased from 10.84% (2,01,98,822 shares) to 7.57% (1,41,01,138 shares). The disclosure was filed under SEBI's substantial acquisition regulations on 11-Apr-26.
Intimation of Installation and commisioning of New Jelly Pouch Production Line
Others (Uncategorized) · 11 Mar 2026, 12:04 am
Arunjyoti Bio Ventures Commissions New Jelly Pouch Line for Tata Consumer Products Arunjyoti Bio Ventures has installed and commissioned a new Jelly Pouch Production Line at its Jangaon facility, with commercial production commencing on 10 Mar'26. The line is specifically set up to manufacture ₹5 Jelly Pouch packs (Lychee and Strawberry flavors) for supply to Tata Consumer Products Limited. This strategic installation is expected to significantly enhance production capacity, meet growing demand, improve operational efficiency, and strengthen the business relationship with its key client, Tata Consumer Products.
Unauited Financial Results along with Limited Review Report for the quarter ended 31.12.2025
Financial Result · 03 Feb 2026, 8:12 pm
Arunjyoti Bio Ventures Reports Q3 FY26 Profit Turnaround Arunjyoti Bio Ventures posted a net profit of ₹4.67 lakhs for the quarter ended 31 Dec'25, a significant turnaround from a ₹88.76 lakh loss YoY and a ₹122.73 lakh loss QoQ. Revenue from operations grew 5.1% YoY and 21.2% QoQ to ₹646.82 lakhs. The profit recovery was driven by higher revenue and a 11.5% YoY reduction in total expenses to ₹641.06 lakhs. The company's basic EPS stood at ₹0.003, compared to -₹0.05 in the prior year's quarter.
Approval of Un-audited financial results along with the Limited Review Report for the quarter ended 31.12.2025
Outcome · 03 Feb 2026, 8:04 pm
Arunjyoti Bio Ventures Swings to Profit in Q3 FY26 Arunjyoti Bio Ventures reported a net profit of ₹4.67 lakhs for the quarter ended 31-Dec'25, a significant turnaround from a loss of ₹122.73 lakhs in the prior quarter and a loss of ₹88.76 lakhs YoY. Total income for the quarter grew 4.5% YoY and 21.2% QoQ to ₹648.01 lakhs. The company’s Profit Before Tax (PBT) stood at ₹6.95 lakhs, compared to a loss of ₹107.69 lakhs QoQ. Basic EPS for Q3 FY26 was ₹0.003, improving from a negative EPS in the preceding quarters.
Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve Un-audited financial ....
Intimation · 03 Feb 2026, 5:30 am
Arunjyoti Bio Ventures Sets Board Meeting for Q3 FY26 Results Arunjyoti Bio Ventures Ltd. (Scrip Code: 530881) has scheduled a Board of Directors meeting on 03 Feb'26. The primary agenda is to consider and approve the un-audited financial results and the Limited Review Report for the third quarter ended 31 Dec'25. The meeting will take place at the company's registered office in Hyderabad.
Outcome
Outcome · 03 Nov 2025, 10:25 pm
Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 ,inter alia, to consider and approve Un-audited Financial ....
Intimation · 03 Nov 2025, 5:30 am
Outcome of Annual General Meeting
Annual General Meeting · 10 Sept 2025, 10:36 pm